Spectrum’s platform includes award-winning medical products to modernize biospecimen collection and preservation for comprehensive genomic and proteomic analysis.
Spectrum’s ISO-certified, onshore & single-site manufacturing, custom engineering capabilities, and domestic supply chain provide integrated, end-to-end solutions aimed at helping partners design, control quality, and produce superior medical solutions.
The rise in remote care has quickly expanded nationwide access to new at-home diagnostic-as-a-service innovation. Spectrum’s test-to-treat partner capabilities seamlessly integrate a tailored compounding solution for patient-specific treatments, customized therapy plans, med-adherence programs, and direct-to-patient dispensing.
Performed in a CAP accredited laboratory our precision molecular test-to-treat capabilities incorporate the highest levels of test sensitivity and specificity for the on-time delivery of accurate and actionable results. Our molecular assays are designed for the simultaneous detection of bacterial, viral, and parasitic agents, as well as virulence determinants for the enhanced ability to manage and treat a variety of infectious diseases.
Pioneering Solutions for Multi-Omic Understanding
For far too long, blood-based diagnostics have been the norm. The rise in remote care has quickly expanded access and elevated clinical laboratory medicine standards nationwide. The evolution of new at-home screening innovations and specialized therapy solutions has empowered individuals to be more in control of their health stories.
Spectrum (BIOMAX-SDNA) has moved quickly to raise awareness of saliva’s diagnostic capabilities, uncovering numerous benefits spanning the -omic and -ology multiverse, helping to drive a new standard of care for patients, clinics, and laboratories. Together we can help provide a superior path forward to safely manage remote care.